A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies
P. Acharya, W. Williams, R. Henderson, K. Janowska, K. Manne, R. Parks, M. Deyton, J. Sprenz, V. Stalls, M. Kopp, K. Mansouri, R. J. Edwards, R. Meyerhoff, T. Oguin, G. Sempowski, , B. F. Haynes
The paper shows that HIV-1 broadly neutralizing antibodies recognize a glycan cluster on the SARS-CoV-2 spike protein, revealing a potential target for vaccine design.
bioRxiv · Jun 30, 2020 · PreprintImmunology